ArticleJournal of experimental & clinical cancer research : CR2025

Tumor-intrinsic ENO1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD-L1 immunotherapy in bladder cancer.

Chengquan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.